Intravenous Thrombolysis for Ischemic Stroke Patients on Dual Antiplatelets.

Georgios TsivgoulisAristeidis H KatsanosDimitris MavridisZuzana GdovinovaMichal Adam KarlinskiMary Joan MacleodDaniel StrbianNiaz Ahmed

Published in: Annals of neurology (2018)

Given that patients on dual antiplatelet pretreatment have similar SICH, 3-month mortality rates, and functional outcomes compared to patients with no antiplatelet pretreatment, dual antiplatelet pretreatment history should not be used as a reason to withhold IVT in otherwise eligible AIS patients. Ann Neurol 2018;83:89-97.

Keyphrases

end stage renal disease
newly diagnosed
chronic kidney disease
ejection fraction
prognostic factors
peritoneal dialysis
type diabetes
patient reported outcomes
high dose
coronary artery disease
acute ischemic stroke